Postdoctoral fellow of Division of Cancer Epidemiology and Genetics, National Cancer Institute
Dirección de correo verificada de
Citado por
Citado por
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAnessPARP1 Inhibitors Trigger Antitumor …
J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ...
Cancer research 79 (2), 311-319, 2019
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou
BMC genomics 15 (1), 1-11, 2014
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ...
Nature medicine 24 (5), 556-562, 2018
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency
C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ...
Cancer cell 33 (3), 401-416. e8, 2018
Characterization of human cancer cell lines by reverse-phase protein arrays
J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ...
Cancer cell 31 (2), 225-239, 2017
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer
K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ...
Cancer cell 21 (5), 626-641, 2012
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1-14, 2019
Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases
KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ...
PLoS medicine 13 (12), e1002174, 2016
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni
Nature Reviews Genetics 18 (7), 395-410, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19 (1), 1-18, 2017
Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered MicePredicting Drug Responsiveness Using GEMMs
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas
J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang
Cancer research 77 (21), e51-e54, 2017
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
X Hua, W Zhao, AC Pesatori, D Consonni, NE Caporaso, T Zhang, B Zhu, ...
Nature communications 11 (1), 1-11, 2020
miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer
D Parashar, A Geethadevi, MR Aure, J Mishra, J George, C Chen, ...
Cell reports 29 (13), 4389-4406. e10, 2019
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor EfficacyVerteporfin Inhibits PD-L1
J Liang, L Wang, C Wang, J Shen, B Su, AL Marisetty, D Fang, C Kassab, ...
Cancer immunology research 8 (7), 952-965, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
L Wang, L Yang, C Wang, W Zhao, Z Ju, W Zhang, J Shen, Y Peng, C An, ...
The Journal of clinical investigation 130 (11), 5951-5966, 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20